01.02.2023
INFORMATION AND PUBLIC RELATIONS DEPARTMENT OF LENINGRAD NPP
The Leningrad NPP increased production of cobalt-60 isotope by 74%
The Leningrad NPP (a branch of Rosenergoatom, part of the Electric Power Division of Rosatom) has exceeded the 2022 plan for the production of isotopes.
Despite external restrictions, the domestic economy is increasing its export potential, delivering goods, services and raw materials around the world. Isotopes in the "range" of the Leningrad nuclear power plant are cobalt-60, iodine-125, molybdenum-99 and iodine-131, used in industry and medicine in the diagnosis and treatment of cancer. For all positions, 2022 was finished with the fulfillment of planned targets.
“We have fulfilled the plan for cobalt-60 by 174%. In 2022, the Leningrad NPP produced up to 27% of the annual global demand for this isotope,” said Vladimir Pereguda, director of the Leningrad NPP. – Industrial sources of ionizing radiation based on cobalt-60 are intended for sterilization and disinfection of food products and medical instruments and materials, stimulation of growth and productivity of grain and vegetable crops, disinfection and purification of industrial effluents, solid and liquid wastes of various types of production, refining and hardening of products from wood and glass.
Cobalt-60 is produced artificially by loading cobalt absorbers into a reactor plant. The process of their irradiation takes up to 5 years. The production of the isotope is performed exclusively at the RBMK units and has been carried out at the Leningrad NPP for more than 25 years.
The goal of the Russian industry is to provide technological sovereignty and the transition to the latest technologies as soon as possible. “Following the Leningrad NPP, the isotope production technology began to be tested at the Kursk and Smolensk NPPs,” said Vladimir Pereguda. “Today, we also have the opportunity to extend the production of isotopes that are so necessary for the national economy and medicine for another 5 years.”
The isotope iodine-131, necessary for the production of radiopharmaceuticals, was supplied by the nuclear power plant to customers for radiochemical processing in an amount sufficient for more than 300,000 oncological procedures. As for the diagnostic isotope - molybdenum-99 (technetium-99m), the produced activity of 3120 GBq delivered to hospitals in St. Petersburg will be enough for 5,000 examinations.
The most important direction is the supply of doped silicon for industries and LNPP has fulfilled them in full. In 2022, over a ton of this most important material, which is used in high-precision integrated circuits, for aircraft construction, space, and military equipment, was sent to enterprises.
The development of radiation technologies today is one of the strategic goals of Rosatom. The market for the development of such technologies in the future is estimated by business experts to be comparable to the nuclear energy market: these are modern diagnostics in medicine, transport security systems, new water and air purification facilities, microelectronics, light industry, metallurgy and many other areas.
In 2023, the Leningrad Nuclear Power Plant plans to introduce the Lutetium-177 isotope into production.
Despite external restrictions, the domestic economy is increasing its export potential, delivering goods, services and raw materials around the world. Isotopes in the "range" of the Leningrad nuclear power plant are cobalt-60, iodine-125, molybdenum-99 and iodine-131, used in industry and medicine in the diagnosis and treatment of cancer. For all positions, 2022 was finished with the fulfillment of planned targets.
“We have fulfilled the plan for cobalt-60 by 174%. In 2022, the Leningrad NPP produced up to 27% of the annual global demand for this isotope,” said Vladimir Pereguda, director of the Leningrad NPP. – Industrial sources of ionizing radiation based on cobalt-60 are intended for sterilization and disinfection of food products and medical instruments and materials, stimulation of growth and productivity of grain and vegetable crops, disinfection and purification of industrial effluents, solid and liquid wastes of various types of production, refining and hardening of products from wood and glass.
Cobalt-60 is produced artificially by loading cobalt absorbers into a reactor plant. The process of their irradiation takes up to 5 years. The production of the isotope is performed exclusively at the RBMK units and has been carried out at the Leningrad NPP for more than 25 years.
The goal of the Russian industry is to provide technological sovereignty and the transition to the latest technologies as soon as possible. “Following the Leningrad NPP, the isotope production technology began to be tested at the Kursk and Smolensk NPPs,” said Vladimir Pereguda. “Today, we also have the opportunity to extend the production of isotopes that are so necessary for the national economy and medicine for another 5 years.”
The isotope iodine-131, necessary for the production of radiopharmaceuticals, was supplied by the nuclear power plant to customers for radiochemical processing in an amount sufficient for more than 300,000 oncological procedures. As for the diagnostic isotope - molybdenum-99 (technetium-99m), the produced activity of 3120 GBq delivered to hospitals in St. Petersburg will be enough for 5,000 examinations.
The most important direction is the supply of doped silicon for industries and LNPP has fulfilled them in full. In 2022, over a ton of this most important material, which is used in high-precision integrated circuits, for aircraft construction, space, and military equipment, was sent to enterprises.
The development of radiation technologies today is one of the strategic goals of Rosatom. The market for the development of such technologies in the future is estimated by business experts to be comparable to the nuclear energy market: these are modern diagnostics in medicine, transport security systems, new water and air purification facilities, microelectronics, light industry, metallurgy and many other areas.
In 2023, the Leningrad Nuclear Power Plant plans to introduce the Lutetium-177 isotope into production.
career
Innovations
Projects
INTERNATIONAL BUSINESS